Hosseinkhani, Shaghayegh, Aazami, Hossein, Hashemi, Ehsan, Dehghanbanadaki, Hojat, Adibi-Motlagh, Behzad, and Razi, Farideh
Due to the importance of omics approaches in diabetes diagnosis, we were assumed to study the scientific activities on omics and type 2 diabetes worldwide. Bibliometric approach was utilized to evaluate the documents on proteomics, lipidomics, and metabolomics in patients with type 2 diabetes in the Scopus database from the beginning to 2020. The articles were screened by two reviewers and the number of publications and citations on omics and type 2 diabetes, top-ranked journals, top-cited articles, country co-contributions, co-authorships, author keywords, and terms were analyzed. The scientific publications in this field consisted of 551 original articles, of which the USA shares the most percent, followed by China and Germany. The frequent keywords showed that the following hotspots were of interest: "Metabolomics, proteomics, and lipidomics as biomarkers for diabetes", "Omics and diabetic nephropathy", "The application of omics in obesity, insulin resistance, and type 2 diabetes". This study showed an increasing trend in applying omics in type 2 diabetes researches and determined the leading producers in this field. Besides, the research hotspots and the main subjects of documents were provided for future research and policy decision-making. • To our knowledge, current original manuscript is the first bibliometric analysis on the omics and type 2 diabetes • USA shares the most percent of publications, China and Germany ranked after the USA • For collaborations, the USA again ranked the first with most of its collaborations with China • Researchers had focused on metabolomics, proteomics, and lipidomics as biomarkers for diabetes and complications [ABSTRACT FROM AUTHOR]